Evidence map›Paper›PMID 34309707›Full record

ReviewEuropean journal of pediatrics2022

Paediatric mitral valve disease - from presentation to management.

Sashini Iddawela, Prince Josiah Sajanthan Joseph, Roshan Ganeshan, Hussain Imtiaz Shah, Temitope Adebowale Temidayo Olatigbe, Anawinla Ta Anyu, Khaled Hadi, Abdulla Tarmahomed, Amer Harky

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Long-term outcomes of mitral valve repair in children.Frontiers in cardiovascular medicine · 2024
    Article
  9. Article
  10. Advances in diagnosis and treatment of mechanical hemolysis following percutaneous interventional for valvular heart diseases.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Sashini IddawelaDepartment of Cardiology, University Hospitals Birmingham, Birmingham, UK. sashini.iddawela@nhs.net.
Prince Josiah Sajanthan JosephSchool of Medicine, University of Liverpool, Liverpool, UK.
Roshan Ganeshan *UCL Medical School, University College London, London, UK.
Hussain Imtiaz Shah *UCL Medical School, University College London, London, UK.
Temitope Adebowale Temidayo OlatigbeMedical University-Sofia, Sofia, Bulgaria.
Anawinla Ta AnyuFaculty of Life Sciences and Medicine, King's College London, London, UK.
Khaled HadiDepartment of Cardiology, Alder Hey Children Hospital, Liverpool, UK.
Abdulla TarmahomedDepartment of Cardiology, Alder Hey Children Hospital, Liverpool, UK.
Amer HarkyDepartment of Cardiology, Alder Hey Children Hospital, Liverpool, UK.
Alder Hey Children's Hospital · GBUniversity College London · GBUniversity of Liverpool · GBKing's College London · GBMedical University of Sofia · BGNIHR Surgical Reconstruction and Microbiology Research Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitral valve diseases are relatively rare in the paediatric population; however, they can cause considerable mortality and morbidity worldwide. Acquired causes are a major contributor to cardiovascular disease burden in the paediatric population. Diseases can be detected before birth, at birth, or when the child is older and presents with symptoms of advanced heart failure. Definitive management consists of surgical intervention, with mitral valve replacement being the gold standard.Conclusion: Repair has been gaining popularity; however, its outcomes require further study. Percutaneous mitral balloon valvuloplasty is an emerging technique which holds promise as a bridge to surgical treatment. The effect of these interventions on quality of life must be emphasised and requires further study. What is Known: • The epidemiology of mitral valve disease in the paediatric population - predominant causes include rheumatic disease and congenital defects.  • Mitral valve repair and replacement are the standard treatment methods for paediatric mitral valve disease.  What is New: • Emergence of percutaneous mitral valve interventions and their potential as bridge-to-surgery or definitive treatment in high-risk surgical candidates.  • Recent evidence comparing mitral valve repair and replacement in the paediatric population demonstrates increasing popularity of repair techniques.

Indexed as

Heart Valve DiseasesMitral Valve InsufficiencyRheumatic Heart DiseaseChildHumansInfant, NewbornMitral ValveQuality of LifeTreatment OutcomeMitralPaediatricRheumaticValve repairValve replacement

Identifiers

PMID34309707
OpenAlexW3183288825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.